Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-108,300
Closed -$1.74M 1665
2020
Q1
$1.74M Buy
+108,300
New +$2.57M 0.02% 748
2019
Q3
Sell
-61,300
Closed -$1.57M 2844
2019
Q2
$1.57M Buy
61,300
+51,300
+513% +$1.43M 0.01% 1057
2019
Q1
$291K Buy
+10,000
New +$259K ﹤0.01% 1808
2014
Q4
Sell
-200,000
Closed -$2.61M 2135
2014
Q3
$2.61M Buy
+200,000
New +$3.02M 0.02% 635
2014
Q2
Sell
-23,700
Closed -$451K 2211
2014
Q1
$451K Buy
+23,700
New +$450K ﹤0.01% 1329

Other funds holding INSM

Jefferies Group's INSM Position: Q3 2022 in Review

Jefferies Group opened a new position in Insmed (INSM) in Q3 2022: 28,550 shares worth $615K. The stake represents 0.01% of the portfolio and ranks #967 among its holdings. This is a return to the name: Jefferies Group previously reported a position in INSM as recently as Q1 2020.

Jefferies Group first reported a position in INSM in Q1 2014 and has held it in 12 quarters since. The position peaked at $3.46M in Q4 2019. 238 funds tracked by Wall St. Rank hold INSM as of Q3 2022.

  • Jefferies Group held 28,550 shares of Insmed worth $615K as of Q3 2022.
  • Insmed was a new Jefferies Group position in Q3 2022.
  • Insmed made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #967 holding.
  • Jefferies Group first reported a position in Insmed in Q1 2014 and has held it in 12 quarters since.
  • Jefferies Group's Insmed position peaked at $3.46M in Q4 2019.
  • 238 funds tracked by Wall St. Rank held Insmed as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.